Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Rabbit Polyclonals
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Rabbit Polyclonals

[0708-PABL-212-2mG.] E. coli Rec. Human monoclonal Anti-IAV HA Antibody, CR9114 Conjug.ation: None Purity: SDS-PAGE>95% Endotoxin: Non-removal 2mG.
E. coli Rec. Human monoclonal Anti-IAV HA Antibody, CR9114 Conjug.ation: None Purity: SDS-PAGE>95% Endotoxin: Non-removal 2mG.
10,080.00 € 10080.0 EUR
[0708-PABL-579] E. coli Rec. Human Anti-HSV gD Antibody (mAb E317), 1 mG.
E. coli Rec. Human Anti-HSV gD Antibody (mAb E317), 1 mG.
5,635.00 € 5635.0 EUR
[0503-8101] Rabbit polyclonal antibody for Vaccinia virus - 1 ml
Rabbit polyclonal antibody for Vaccinia virus - 1 ml
553.00 € 553.0 EUR
[0800-F49621-0.4ML] Rabbit polyclonal anti-parkin (PARK2) antibody , 0
Rabbit polyclonal anti-parkin (PARK2) antibody , 0
685.00 € 685.0 EUR
[0118-20R-RR007] Rabbit polyclonal Sheep RBC Antibody - 20mG.
Rabbit polyclonal Sheep RBC Antibody - 20mG.
652.00 € 652.0 EUR
[0544-MBS711316] Rabbit anti-human leucine rich repeat containing 8 family, member C pAb - 0.05mL
Rabbit anti-human leucine rich repeat containing 8 family, member C pAb - 0.05mL
383.00 € 383.0 EUR
[0399-CSB-PA322729ZA01VAA-100ul] Rabbit anti-Vaccinia virus (strain Copenhagen) (VACV) E3L Polyclonal antibody 100ul
Rabbit anti-Vaccinia virus (strain Copenhagen) (VACV) E3L Polyclonal antibody 100ul
475.00 € 475.0 EUR
[0544-MBS524190-10ML] Rabbit anti-Sheep RBC Polyclonal Antibody (rabbit serum) - 5x2mL
Rabbit anti-Sheep RBC Polyclonal Antibody (rabbit serum) - 5x2mL
1,574.00 € 1574.0 EUR
[0544-MBS524190-2ML] Rabbit anti-Sheep RBC Polyclonal Antibody (rabbit serum) - 2mL
Rabbit anti-Sheep RBC Polyclonal Antibody (rabbit serum) - 2mL
502.00 € 502.0 EUR
[0494-0302-030] Rabbit anti-SUDV soluble GP (sGP) pAb - 100ug.
Rabbit anti-SUDV soluble GP (sGP) pAb - 100ug.
602.00 € 602.0 EUR
[0494-0302-001] Rabbit anti-SUDV VP40 pAb - 100ug.
Rabbit anti-SUDV VP40 pAb - 100ug.
627.00 € 627.0 EUR
[0494-0302-012] Rabbit anti-SUDV NP pAb - 100ug.
Rabbit anti-SUDV NP pAb - 100ug.
627.00 € 627.0 EUR
[0494-0302-020] Rabbit anti-SUDV GP pAb - 500 ug.
Rabbit anti-SUDV GP pAb - 500 ug.
806.00 € 806.0 EUR
[0494-0305-001] Rabbit anti-RESTV GP pAb, 100 ug.
Rabbit anti-RESTV GP pAb, 100 ug.
675.00 € 675.0 EUR
[0494-0303-001] Rabbit anti-MARV VP40 polyclonal antibody - 100 ug.
Rabbit anti-MARV VP40 polyclonal antibody - 100 ug.
792.00 € 792.0 EUR
[0494-04-0005] Rabbit anti-MARV VLP pAb - 500 ug.
Rabbit anti-MARV VLP pAb - 500 ug.
515.00 € 515.0 EUR
[0494-0303-012] Rabbit anti-MARV NP pAb - 100ug.
Rabbit anti-MARV NP pAb - 100ug.
792.00 € 792.0 EUR
[0494-0303-007-bio] Rabbit anti-MARV GP pAb Biotinylated - 100 ug.
Rabbit anti-MARV GP pAb Biotinylated - 100 ug.
828.00 € 828.0 EUR
[0494-0303-007] Rabbit anti-MARV GP pAb - 100ug.
Rabbit anti-MARV GP pAb - 100ug.
806.00 € 806.0 EUR
[0494-0317-001] Rabbit anti-LukB pAb - 100ug.
Rabbit anti-LukB pAb - 100ug.
595.00 € 595.0 EUR
  • 6
  • 7
  • 8
  • 9
  • 10

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)